Dustin S Sjuts is President of Revance Therapeutics, Inc.. Currently has a direct ownership of 167,550 shares of RVNC, which is worth approximately $430,603. The most recent transaction as insider was on Feb 02, 2021, when has been sold 22,620 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 168K
0% 3M change
3.38% 12M change
Total Value Held $430,603

Dustin S Sjuts Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 02 2021
BUY
Grant, award, or other acquisition
-
22,620 Added 24.98%
67,919 Common Stock
Dec 31 2020
BUY
Other acquisition or disposition
$7,433 $21.36 p/Share
348 Added 0.76%
45,299 Common Stock
Dec 15 2020
SELL
Payment of exercise price or tax liability
$15,034 $26.75 p/Share
562 Reduced 1.23%
44,951 Common Stock
Sep 30 2020
SELL
Payment of exercise price or tax liability
$152,122 $25.14 p/Share
6,051 Reduced 11.73%
45,513 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
-
17,500 Added 25.34%
51,564 Common Stock
DSS

Dustin S Sjuts

President
Nashville, TN

Track Institutional and Insider Activities on RVNC

Follow Revance Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC